Paxlovid

Paxlovid is Pfizer's antiviral medication to treat COVID-19. (Reuters/Wolfgang Rattay/Illustration)When the antiviral medication Paxlovid was approved in 2021 to treat COVID-19, doctors began noticing a perplexing trend among some of the…

May 28 (Reuters) - Use of Pfizer Inc's (PFE.N) COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after…

NEW YORK (WABC) -- The CDC has shortened the amount of time people who are moderately or severely immunocompromised need to wait before getting a fourth COVID vaccine booster dose.They now recommend that the severely immunocompromised…